本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

89.82
-0.9600-1.06%
盘后:89.820.00000.00%16:00 EDT
成交量:53.80万
成交额:4,844.07万
市值:61.84亿
市盈率:-28.81
高:91.42
开:91.05
低:89.49
收:90.78
52周最高:122.20
52周最低:74.50
股本:6,885.21万
流通股本:6,539.41万
量比:0.50
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
净资产收益率:-117.04%
总资产收益率:-30.96%
市净率:60.05
市盈率(LYR):-28.88

数据加载中...

2026/09/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/03

重要事件披露

Form 8-K - Current report
2026/03/27

重要事件披露

Form 8-K - Current report